Modern possibilities for the treatment of patients with bacterial vaginosis and candidiasis of the lower reproductive tract
The objective. To assess the efficacy of the original combined medication Vagisept® (vaginal suppositories) in the local treatment of patients with various forms of vaginal infectious diseases. Patients and methods. A total of 45 women with infectious diseases of the vagina participated in the study. The first group (n = 28) included patients with vulvovaginal candidiasis. In the second group (n = 17) there were women with bacterial vaginosis. The medication Vagisept® was administered intravaginally once daily at bedtime for 10 consecutive days. The treatment efficacy was evaluated based on the dynamics of clinical manifestations, microscopic and bacteriological parameters of the vaginal discharge. Results. In the first group, only five out of 28 patients (17.9%) had yeast fungi, resulting in the overall treatment efficacy of 82.1%. In the second group, we observed 100% efficacy of the therapy in all patients. Long-term results showed no relapses of bacterial vaginosis, a recurrence of vulvovaginal candidiasis was noted in only one patient. Conclusion. The combined medication Vagisept® is an effective means for the treatment of patients with various forms of vaginal infectious diseases.